Syneos Health Names Michelle Keefe as Next Chief Executive Officer
29 avr. 2022 06h26 HE
|
Syneos Health, Inc.
Alistair Macdonald to Retire After 20 Years in Variety of Leadership Roles Michael Brooks Named Chief Operating Officer Company Reports First Quarter 2022 Results and Updates Full Year Guidance ...
Syneos Health Reports First Quarter 2022 Results
29 avr. 2022 06h24 HE
|
Syneos Health, Inc.
Highlights Revenue for the first quarter of $1,336.3 million increased 10.5% on a reported basis and 11.7% on a constant currency basis year-over-year.Clinical Solutions net new business...
Syneos Health Reports Third Quarter 2021 Results
03 nov. 2021 06h16 HE
|
Syneos Health, Inc.
Highlights Third quarter revenue of $1,348.2 million increased 22.7% year-over-year.Clinical Solutions net new business awards of $1,353.8 million for the third quarter, representing year-over-year...
Syneos Health Reports First Quarter 2021 Results
29 avr. 2021 06h16 HE
|
Syneos Health, Inc.
Highlights Revenue of $1,208.7 million for the three months ended March 31, 2021, representing a sequential increase of 6.0% compared to the three months ended December 31, 2020, and a...
Syneos Health® Launches Kinetic™ Omnichannel Capability to Accelerate Modern Customer Engagement
21 oct. 2020 06h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today introduced Kinetic, a modern customer...
INC Research/inVentiv Health to Present at Upcoming J.P. Morgan Healthcare Conference
14 déc. 2017 18h09 HE
|
INC Research, LLC
RALEIGH, N.C., Dec. 14, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive...
INC Research/inVentiv Health to Present at Upcoming Jefferies 2017 London Healthcare Conference
03 nov. 2017 16h31 HE
|
INC Research, LLC
RALEIGH, N.C., Nov. 03, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive...
INC Research to Present at Upcoming Nasdaq Investor Conference
14 nov. 2016 16h15 HE
|
INC Research, LLC
RALEIGH, N.C., Nov. 14, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that Chief...